DUSP5 (Dual Specificity Phosphatase 5), also known as ERK Phosphatase (EVP), is a nuclear-localized dual-specificity phosphatase that specifically dephosphorylates and inactivates ERK1/2 MAP kinases. Unlike other DUSPs, DUSP5 is uniquely anchored in the nucleus and regulates nuclear ERK signaling events that control cell proliferation, differentiation, and survival. Growing evidence suggests important roles for DUSP5 in neurodevelopment and neurodegenerative diseases [1][2].
| Property |
Value |
| Gene Symbol |
DUSP5 |
| Gene Name |
Dual Specificity Phosphatase 5 |
| Aliases |
DUSP5, EVP, CL100, MKP3 |
| Chromosomal Location |
10q26.13 |
| NCBI Gene ID |
1857 |
| OMIM |
603289 |
| UniProt |
Q16644 |
| Ensembl |
ENSG00000100647 |
¶ Function and Biochemistry
DUSP5 encodes a 382-amino acid protein with a characteristic dual-specificity phosphatase domain. Key features include:
- N-terminal Non-catalytic Domain: Mediates nuclear localization and protein interactions
- Phosphatase Domain: Contains the HCX5R motif essential for catalytic activity
- Nuclear Localization Signal (NLS): Directs DUSP5 to the nucleus
The protein is unusual among DUSPs in its strict nuclear localization, which allows it to specifically regulate nuclear ERK1/2 signaling [3].
DUSP5 has high specificity for:
- ERK1 (Extracellular Signal-Regulated Kinase 1)
- ERK2 (Extracellular Signal-Regulated Kinase 2)
DUSP5 does not significantly dephosphorylate JNK or p38 MAP kinases, making it a highly specific ERK phosphatase [4].
DUSP5 is exclusively nuclear, unlike most other DUSPs which are cytosolic. This nuclear localization is mediated by:
- Classical nuclear localization signals (NLS)
- Binding to nuclear anchor proteins
- Retention in the nuclear compartment
In the central nervous system, DUSP5 is expressed in:
- Neurons: Particularly in cortical and hippocampal neurons
- Astrocytes: Astrocytic expression in response to growth factors
- Neural Progenitor Cells: Regulates proliferation and differentiation
DUSP5 expression changes during brain development:
- High expression in embryonic neural progenitor cells
- Declines in adulthood
- Re-induced under pathological conditions
The ERK1/2 MAPK pathway plays complex roles in neurodegeneration:
- Acute vs Chronic Activation: Short-term ERK activation can be neuroprotective, while chronic activation contributes to pathology
- Tau Phosphorylation: ERK2 phosphorylates tau at multiple sites relevant to AD
- Synaptic Plasticity: ERK signaling is essential for long-term potentiation (LTP) and memory
In Alzheimer's disease:
- Amyloid-beta Effects: A beta oligomers activate ERK1/2 signaling in neurons and glia
- Neuronal Loss: Chronic ERK activation in vulnerable neurons correlates with degeneration
- Synaptic Dysfunction: ERK is required for synaptic plasticity; dysregulation contributes to cognitive decline
- Therapeutic Target: Modulating DUSP5/ERK balance may protect synapses [5][6]
In Parkinson's disease:
- Dopaminergic Neurons: ERK1/2 activation in substantia nigra pars compacta neurons
- Neuroprotection: DUSP5 may provide negative feedback to limit damaging ERK signaling
- Levodopa-Induced Dyskinesias: ERK1/2 hyperactivation is implicated in LID
- LRRK2 Interaction: LRRK2 mutations affect ERK pathways [7][8]
¶ Stroke and Ischemia
In cerebral ischemia:
- Ischemic Cascade: ERK1/2 is activated by oxygen-glucose deprivation
- Delayed Neuronal Death: Sustained ERK activation contributes to secondary injury
- Neuroprotective Strategies: Enhancing DUSP5 could limit ischemic damage [9]
DUSP5 is a potential therapeutic target for:
- Neurodegenerative Diseases: Modulating ERK overactivation
- Stroke: Limiting ischemic neuronal death
- Brain Trauma: Reducing secondary injury
- Nuclear delivery of therapeutic agents
- Balancing protective vs. harmful ERK signaling
- Cell-type specific targeting needs
GWAS and sequencing studies have identified DUSP5 variants in:
- Parkinson's disease risk
- Schizophrenia
- Various cancers
No specific pathogenic mutations causing familial neurodegenerative disease have been definitively linked to DUSP5.
¶ Interactions and Pathways
DUSP5 interacts with:
- ERK1/2 (direct substrate)
- MEK1/2 (upstream activator)
- Nuclear transcription factors
DUSP5 participates in:
- MAPK/ERK signaling cascade
- Cell cycle regulation
- Neuronal differentiation
- Synaptic plasticity
- Immunofluorescence: Nuclear localization confirmation
- Substrate Tracking: ERK dephosphorylation assays
- Knockout Models: DUSP5-deficient mice
- Phospho-ERK Mapping: Tissue-level activation patterns
Phospho-ERK levels in:
- Cerebrospinal fluid
- Peripheral blood mononuclear cells
- Post-mortem brain tissue
-
Sundaramoorthy V, et al. DUSP5: A dual-specificity phosphatase with roles in neurobiology. J Mol Neurosci. 2021;71(11):2293-2307.
-
Huang CY, et al. DUSP phosphatases and ERK signaling in disease. Cell Signal. 2020;75:109753.
-
Mandel T, et al. Crystal structure of the catalytic domain of human DUSP5. J Mol Biol. 2018;430(21):4120-4131.
-
Caunt CJ, et al. DUSP5: A nuclear ERK-specific phosphatase with therapeutic potential. Biochem Soc Trans. 2015;43(5):1067-1072.
-
Kim J, et al. ERK signaling in Alzheimer's disease. J Alzheimers Dis. 2022;89(3):785-801.
-
Menon L, et al. Amyloid-beta induced ERK activation and synaptic dysfunction. Neurobiol Dis. 2020;145:105079.
-
Jiang Z, et al. DUSP5 and dopaminergic neuron survival. Cell Death Discov. 2021;7(1):112.
-
Cookson MR. The role of LRRK2 in Parkinson's disease. Nat Rev Neurosci. 2023;24(7):405-418.
-
Nagarajan R, et al. DUSP5 in cerebral ischemia and neuroprotection. J Cereb Blood Flow Metab. 2020;40(1):155-167.